<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Omega</journal-id><journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id><journal-id journal-id-type="publisher-id">ao</journal-id><journal-id journal-id-type="coden">acsodf</journal-id><journal-title-group><journal-title>ACS Omega</journal-title></journal-title-group><issn pub-type="epub">2470-1343</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7839156</article-id><article-id pub-id-type="doi">10.1021/acsomega.0c05701</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>SARSCOVIDB&#x02014;A New Platform for the Analysis
of the Molecular Impact of SARS-CoV-2 Viral Infection</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>da Rosa</surname><given-names>Rafael Lopes</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Yang</surname><given-names>Tung Sheng</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Tureta</surname><given-names>Emanuela Fernanda</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>de Oliveira</surname><given-names>Laura Rascovetzki
Saciloto</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Moraes</surname><given-names>Amanda Naiara Silva</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Tatara</surname><given-names>Juliana Miranda</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Costa</surname><given-names>Renata Pereira</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Borges</surname><given-names>J&#x000fa;lia Spier</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath9"><name><surname>Alves</surname><given-names>Camila Innocente</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath10"><name><surname>Berger</surname><given-names>Markus</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath11"><name><surname>Guimar&#x000e3;es</surname><given-names>Jorge Almeida</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath12"><name><surname>Santi</surname><given-names>Luc&#x000e9;lia</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath13"><name><surname>Beys-da-Silva</surname><given-names>Walter Orlando</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o
em Biologia Celular e Molecular, <institution>Universidade
Federal do Rio Grande do Sul</institution>, Avenida Bento Gon&#x000e7;alves 9500, pr&#x000e9;dio
43431, Porto Alegre, Rio
Grande do Sul 91501-970, <country>Brasil</country></aff><aff id="aff2"><label>&#x02021;</label>Faculdade de Farm&#x000e1;cia, <institution>Universidade Federal do Rio Grande do Sul</institution>, Avenida Ipiranga 2752, Porto
Alegre, Rio Grande do Sul 90610-000, <country>Brasil</country></aff><aff id="aff3"><label>&#x000a7;</label>Centro de Pesquisa
Experimental, <institution>Hospital de Cl&#x000ed;nicas
de Porto Alegre</institution>, Rua
Ramiro Barcelos, 2350, Porto Alegre, Rio Grande do Sul 90035-903, <country>Brasil</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>lucelia.santi@ufrgs.br</email>. Phone: <phone>+55 (51) 3308-5304</phone>.</corresp><corresp id="cor2"><label>*</label>Email: <email>walter.beys@ufrgs.br</email>. Phone: <phone>+55 (51) 3308-5354</phone>.</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>01</month><year>2021</year></pub-date><pub-date pub-type="collection"><day>02</day><month>02</month><year>2021</year></pub-date><volume>6</volume><issue>4</issue><fpage>3238</fpage><lpage>3243</lpage><history><date date-type="received"><day>23</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>13</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 The Authors. Published by American
Chemical Society</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>The Authors</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05701_0004" id="ab-tgr1"/></p><p>The COVID-19
pandemic caused by the new coronavirus (SARS-CoV-2) has become a global
emergency issue for public health. This threat has led to an acceleration
in related research and, consequently, an unprecedented volume of
clinical and experimental data that include changes in gene expression
resulting from infection. The SARS-CoV-2 infection database (SARSCOVIDB: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://sarscovidb.org/">https://sarscovidb.org/</uri>) was
created to mitigate the difficulties
related to this scenario. The SARSCOVIDB is an online platform that
aims to integrate all differential gene expression data, at messenger
RNA and protein levels, helping to speed up analysis and research
on the molecular impact of COVID-19. The database can be searched
from different experimental perspectives and presents all related
information from published data, such as viral strains, hosts, methodological
approaches (proteomics or transcriptomics), genes/proteins, and samples
(clinical or experimental). All information was taken from 24 articles
related to analyses of differential gene expression out of 5,554 COVID-19/SARS-CoV-2-related
articles published so far. The database features 12,535 genes whose
expression has been identified as altered due to SARS-CoV-2 infection.
Thus, the SARSCOVIDB is a new resource to support the health workers
and the scientific community in understanding the pathogenesis and
molecular impact caused by SARS-CoV-2.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ao0c05701</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ao0c05701</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>In December 2019, a
new strain of coronavirus associated with severe
acute respiratory syndrome was identified as SARS-CoV-2.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> This is an encapsulated, single-stranded RNA
virus from the <italic>Coronaviridae</italic> family, presenting high
virulence and generating a significant global impact.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> The COVID-19 pandemic caused by SARS-CoV-2 had as its epicenter
the city of Wuhan, China, and in a short time became a serious public
health problem worldwide.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> As of end-October,
it is present in more than 200 countries, accounting for 45 million
cases.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> In the USA, the country with the
highest number of deaths, more than 8 million cases and 220,000 deaths
have been recorded.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> The same dramatic
outcome of the pandemic can be noticed in Brazil, the country with
the second highest number of COVID-19 deaths, with more than 5 million
cases and 150,000 deaths.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p><p>The increasing
proliferation of SARS-CoV-2-infection cases and the lack of specific
therapeutics and vaccines have caused concern among public authorities
and international agencies, resulting in the mobilization of the scientific
community to understand the disease and clinical outcomes aiming to
improve treatments and find ways to prevent COVID-19 cases. This current
scenario has generated significant changes in the field, such as a
rapid and unprecedented increase in the number of scientific articles
being published. It was possible through facilitated submission processes
and preprint publications, without peer evaluation, to disseminate
articles with very speculative results, such as computational predictions.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p><p>Understanding of the molecular aspects
associated with COVID-19 and the search for understanding the complex
response of the host after viral infection have been gaining space.<sup><xref ref-type="bibr" rid="ref7">7</xref>&#x02212;<xref ref-type="bibr" rid="ref9">9</xref></sup> Approaches that evaluate viral
infections from the perspective of the molecular impact on the host
contribute to the understanding of the disease, which is important
for outlining potential antiviral strategies.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Analysis of differentially expressed genes (DEGs), which allow <italic>in silico</italic> characterization of the molecular response and
the impact of infection, can be applied. Some databases contain a
collection of expression data, but their results are mostly obtained
by text mining with automatic and semiautomatic approaches, which
may lead to nonaccurate data being deposited.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Furthermore, the results may present redundancy and ambiguity, and
a postanalysis is necessary for data conference.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> In the same way, the need for bioinformaticians to extract
raw data in many of the available databases is another important limitation
of its use; it can be especially limiting for medical workers without
bioinformatics skills who are facing the COVID-19 impact in real time
and need information promptly. This scenario hampers the access of
the medical community and also other nonspecialized scientists who
may need this information in their research. Recently, our group developed
the ZIKAVID, a database based on gathering all up-to-date gene expression
data generated after Zika virus (ZIKV) infection, containing different
experimental approaches, hosts and strains, and other related information.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup></p><p>In this work, we present the SARS-CoV-2
virus infection database (SARSCOVIDB: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://sarscovidb.org/">https://sarscovidb.org/</uri>), a public
database containing all DEGs identified in SARS-CoV-2
infection and COVID-19 samples, manually developed and checked, with
a friendly interface that is easy to navigate. This database will
help researchers worldwide, and general users, to speed up the research
and understanding of the molecular impact of COVID-19 and possible
clinical outcomes.</p></sec><sec id="sec2"><title>Results and Discussion</title><p>The outbreak
of COVID-19 worldwide, linked to the lack of efficient
treatments and approved vaccines, triggered a great effort by the
scientific community and governments toward research involving SARS-CoV-2
and the potential comorbidities associated in humans.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> For this reason, the SARSCOVIDB was created, comprising
all data from DEGs identified after SARS-CoV-2 infection to date.</p><p>The database was initially built by searching the specific terms
&#x0201c;COVID&#x0201d; and &#x0201c;SARS-CoV-2&#x0201d;, with a manual
double-check for differential expression of genes or proteins after
SARS-CoV-2 infection, regardless of the host. To increase the search
and the user interface, all data were categorized according to experimental
approach, as described above, including the reference article. The
SARSCOVIDB is a database to exclusively gather DEGs after SARS-CoV-2
infection and thus is an important resource to be explored by the
scientific community and COVID-19 medical workers in this topic of
urgent need. So far, the SARSCOVIDB contains 12,535 differential DEG
entries and 9,283 unique genes. These data comprise different experimental
approaches with distinct objectives, the majority being obtained from
clinical samples (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A). Thus, users can easily consult the most frequently reported
host models and compare specific gene sets and other information from
all published studies with differential expression after SARS-CoV-2
infection. This can facilitate the planning of new experiments, accelerating
understanding of the data available and contributing to accelerate
understanding of the molecular impact of COVID-19. These expressive
numbers in such a short time span of only a few months also highlight
the great efforts made by the scientific community to study SARS-CoV-2
infection and COVID-19. The ZIKAVID covered the same kind of data
but on ZIKV; however, this generated a smaller number of clinical
samples of ZIKV-infected patients,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> even
though the epidemic also reached a global threat status<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> and caused great concern worldwide in 2015&#x02013;2017.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>SARSCOVID
summary of
contents. (A) Number of DEGs identified in clinical and experimental
samples; (B) number of articles containing clinical samples; (C) number
of articles containing experimental samples; (D) number of articles
according to the reported origin of SARS-CoV-2 strain; (E) number
of articles according to the methodological approach.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05701_0002" id="gr1" position="float"/></fig><p>Regarding the samples used, most are peripheral blood samples
(five
serum, four blood, and two plasma samples) and one lung sample (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). On the other
hand, the experimental samples used different cell lines, most of
them from humans (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C). As observed, many scientific data have been generated
using cell lines and other models but there are still no robust animal
models that faithfully replicate the pathogenesis of SARS-CoV-2.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> Thus, the lack of comprehensive studies comparing
different hosts and their responses to infection made the survey of
data gathered in the SARSCOVIDB an important alternative to planning
future experiments regarding the choice of a more meaningful experimental
model.</p><p>The SARSCOVIDB comprises data from SARS-CoV-2 isolates
from different geographic regions (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D). However, studies have still given little
importance to the impact that the mutations suffered by strains in
different regions may have on disease dynamics and virulence, as occurred
with ZIKV for instance.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Interestingly,
almost 50% of the SARS-CoV-2 isolates or clinical samples studied
are from China, followed by America (around 16%) and Europe (around
16%). It is important to highlight that depending on the origin, viral
isolates of SARS-CoV-2 can lead to different pathological impacts
and mortality rates, as previously suggested.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> The most recent example of a virus that had a differential clinical
impact, depending on the origin, was ZIKV, where Brazilian isolates
were strongly associated with severe neurological data.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> Thus, the SARSCOVIDB contributes to the study
of the pathology on the origin of the virus, once it is possible to
promptly cross-reference expression data in similar models using viruses
from different sources.</p><p>Currently, there are various databases
gathering genomic, transcriptomic, and proteomic data on viruses and
their impact on the host.<sup><xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup> Several databases were
developed to obtain host&#x02013;pathogen interaction data (gene expression
and protein interaction), such as VirHostNet 2.0,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> Virhostome,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> the HIV-1 human
interaction database,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> the Gene Expression
Omnibus,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> and the Virus Pathogen Resource
(ViPR).<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> On SARS-CoV-2, there are already
two databases: Coronascape,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> available
at Metascape database, and The COVID-19 Drug and Gene Set Library,<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> which contain a collection of drug and gene
sets related to COVID-19. Although not the first SARS-CoV-2 database,
SARSCOVIDB is certainly the first to devote itself exclusively to
this specific focus on differential expression after the SARS-CoV-2
infection. Most of the data generated by other databases are automated
by concentrating generic information, which can result in inaccurate
information.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> The SARSCOVIDB proposes
to fill this gap in a simple, organized, and objective way by curating
the data manually, making it reliable. Furthermore, the user, who
does not need a bioinformatic background or skills, can query data
from different experimental perspectives, such as the methodology
used, host, virus strain, and so forth.</p></sec><sec id="sec3"><title>Conclusions</title><p>The
SARSCOVIDB is the first database to gather
all data to date from differential expression analyses after SARS-CoV-2
infection, with manual checking of the data to give more accurate
and faster analysis. Users do not need to have a background in bioinformatics
because the user-friendly and simple interface enables all search
possibilities to be explored. This allows the user to cross-reference
data for the best understanding and analysis of the deposited data.
Finally, the SARSCOVIDB is a promising tool for supporting scientists
and medical professionals carrying out research and analysis on the
molecular mechanisms of SARS-CoV-2 infection.</p></sec><sec id="sec4"><title>Materials and Methods</title><sec id="sec4.1"><title>Original
Article Selection</title><p>The SARSCOVIDB (available at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://sarscovidb.org/">https://sarscovidb.org/</uri>) comprises
differential gene expression measurements, at mRNA and
protein levels, built through four main steps (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). The first step was a manual search by
manual text mining to find all articles available in PubMed, Web of
Science, Google Scholar, and ScienceDirect databases containing the
terms &#x0201c;SARS-CoV-2&#x0201d; and &#x0201c;COVID-19&#x0201d;. Only
accepted/published manuscripts were used as the source of DEGs in
SARS-CoV2 infection. This search retrieved 5554 articles, from December
2019 to date. The second step comprised a manual check of abstracts
to select articles containing only differential gene expression measurements
after SARS-CoV-2 infection. All references were double-checked by
two independent individuals, resulting in the selection of 24 articles.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Database
construction
steps.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05701_0003" id="gr2" position="float"/></fig></sec><sec id="sec4.2"><title>Data Collection and Related
Information</title><p>The data collected
from selected papers were checked and organized,
comprising a list of DEGs at mRNA and/or protein level identified
after SARS-CoV-2 infection. Other information was also collected,
such as the type of study (<italic>in vivo</italic>, <italic>in vitro</italic>, and clinical), methodological approach (transcriptomic, proteomic,
qRT-PCR, and immunoblotting), viral strain, hosts (clinical or animal
model and cell culture), and expression status (see <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). The SARSCOVIDB also contains
information from data deposited in a repository or database. The database
will be updated at least monthly by considering the availability of
new data from published articles.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>General Information
Stored in the
SARSCOVIDB</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/></colgroup><tbody><tr><td style="border:none;" align="left">SARSCOVIDB ID</td><td style="border:none;" align="left">reference identification of the entry in the SARSCOVIDB.</td></tr><tr><td style="border:none;" align="left">gene name</td><td style="border:none;" align="left">official gene name for each
stored entry.</td></tr><tr><td style="border:none;" align="left">protein name</td><td style="border:none;" align="left">official protein name for each stored entry.</td></tr><tr><td style="border:none;" align="left">host/sample</td><td style="border:none;" align="left">host model
used to generate SARS-COV-2 infection
data.</td></tr><tr><td style="border:none;" align="left">sample</td><td style="border:none;" align="left">description of
the sample, such as if it is a human clinical sample (blood, urine,
serum, <italic>etc.</italic>) or experimental sample (cell line or
animal tissue tested <italic>in vitro</italic>).</td></tr><tr><td style="border:none;" align="left">virus reference</td><td style="border:none;" align="left">SARS-CoV-2 strain reference or geographic origin of the SARS-CoV-2 viral isolate or clinical sample.</td></tr><tr><td style="border:none;" align="left">methods</td><td style="border:none;" align="left">methods used to measure gene expression at the level of RNA and/or protein after SARS-CoV-2 infection.</td></tr><tr><td style="border:none;" align="left">expression</td><td style="border:none;" align="left">indicates
the identified gene expression <italic>status</italic> (up-&#x000a0;and/or&#x000a0;downregulated) in response to SARS-CoV-2 infection.</td></tr><tr><td style="border:none;" align="left">article</td><td style="border:none;" align="left">article title used as a data source.</td></tr><tr><td style="border:none;" align="left">DOI</td><td style="border:none;" align="left">direct link to the original reference where the
data came from.</td></tr><tr><td style="border:none;" align="left">type of sample</td><td style="border:none;" align="left">indicates if the data were generated using clinical or experimental
samples.</td></tr></tbody></table></table-wrap></sec><sec id="sec4.3"><title>Webpage Construction
and
User Interface</title><p>The last step in
the SARSCOVIDB was webpage development (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). MySQL v5.0, PHP v.5.2.99, and HTML10 were
used to build the database and the graphical user interface. The data
were stored and maintained by the relational database management system
(RDBMS) server, with the SQL language used for data management. The
search can be customized easily by the user, combining specific proteins
with hosts or selecting a specific viral strain or geographic origin.
The database also provides step-by-step links to instruct the user
how to search. A list containing all genes deposited in the SARSCOVIDB
is available through direct download (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://sarscovidb.org/download/">https://sarscovidb.org/download/</uri>).</p></sec></sec></body><back><notes notes-type="" id="notes1"><title>Author Contributions</title><p>R.L.d.R:
methodology, web design, data collection and curation, formal analysis,
investigation, and writing&#x02014;original draft; T.S.Y.: methodology,
data collection and curation, formal analysis, investigation, and
writing&#x02014;original draft; E.F.T., L.R.S.d.O., A.N.S.M., J.M.T.,
R.P.C., J.S.B., and C.I.A.: methodology and data collection and curation;
M.B. and J.A.G.: writing&#x02014;review and editing; and L.S.: investigation
and writing&#x02014;review and editing. W.O.B.-d.-S.: conceptualization,
methodology, investigation, supervision, and writing&#x02014;review
and editing.</p></notes><notes notes-type="COI-statement" id="NOTES-d7e573-autogenerated"><p>The authors declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The authors would
like to thank the Brazilian agency Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento
de Pessoal de N&#x000ed;vel Superior (CAPES) for financial support.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="weblink" id="cit1"><person-group person-group-type="allauthors"><collab>WHO</collab></person-group>, <article-title>Statement on the second meeting of the International
Health Regulations (2005) Emergency Committee regarding the outbreak
of novel coronavirus (2019-nCoV)</article-title>. Available in: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)">https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)</uri>; <publisher-name>World Health Organization</publisher-name>, <year>2020</year>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Wrapp</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>N.</given-names></name>; <name><surname>Corbett</surname><given-names>K. S.</given-names></name>; <name><surname>Goldsmith</surname><given-names>J. A.</given-names></name>; <name><surname>Hsieh</surname><given-names>C.-L.</given-names></name>; <name><surname>Abiona</surname><given-names>O.</given-names></name>; <name><surname>Graham</surname><given-names>B. S.</given-names></name>; <name><surname>McLellan</surname><given-names>J. S.</given-names></name>
<article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion
conformation</article-title>. <source>Science</source>
<year>2020</year>, <volume>367</volume>, <fpage>1260</fpage>&#x02013;<lpage>1263</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb2507</pub-id>.<pub-id pub-id-type="pmid">32075877</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="weblink" id="cit3"><person-group person-group-type="allauthors"><collab>WHO</collab></person-group>, <article-title>WHO Statement regarding cluster of
pneumonia cases in Wuhan, China</article-title>. Available in: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china">https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china</uri>; <publisher-name>World Health Organization</publisher-name>, <year>2020</year>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="weblink" id="cit4"><person-group person-group-type="allauthors"><collab>JHU CSSE</collab></person-group>. <article-title>COVID-19 Dashboard by the Center for Systems Science
and Engineering (CSSE)</article-title>. Available in: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://coronavirus.jhu.edu/map.html">https://coronavirus.jhu.edu/map.html</uri>; <publisher-name>John Hopkins University</publisher-name>, <year>2020</year>.</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="weblink" id="cit5"><person-group person-group-type="allauthors"><collab>CONASS. Conselho Nacional de
Secret&#x000e1;rios de Sa&#x000fa;de</collab></person-group>. <article-title>Painel COVID-19</article-title>. Available in: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.conass.org.br/">https://www.conass.org.br/</uri>, <year>2020</year>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Horbach</surname><given-names>S.
P. J. M.</given-names></name>
<article-title>Pandemic Publishing:
Medical journals drastically speed up their publication process for
Covid-19</article-title>. <source>Quant. Sci. Studies.</source>
<year>2020</year>, <volume>1</volume>, <fpage>1056</fpage>&#x02013;<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1162/qss_a_00076</pub-id>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Bojkova</surname><given-names>D.</given-names></name>; <name><surname>Klann</surname><given-names>K.</given-names></name>; <name><surname>Koch</surname><given-names>B.</given-names></name>; <name><surname>Widera</surname><given-names>M.</given-names></name>; <name><surname>Krause</surname><given-names>D.</given-names></name>; <name><surname>Ciesek</surname><given-names>S.</given-names></name>; <name><surname>Cinatl</surname><given-names>J.</given-names></name>; <name><surname>M&#x000fc;nch</surname><given-names>C.</given-names></name>
<article-title>Proteomics
of SARS-CoV-2-infected host cells reveals therapy targets</article-title>. <source>Nature</source>
<year>2020</year>, <volume>583</volume>, <fpage>469</fpage>&#x02013;<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2332-7</pub-id>.<pub-id pub-id-type="pmid">32408336</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Ouyang</surname><given-names>Y.</given-names></name>; <name><surname>Yin</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Shi</surname><given-names>H.</given-names></name>; <name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>B.</given-names></name>; <name><surname>Qiao</surname><given-names>L.</given-names></name>; <name><surname>Feng</surname><given-names>Y.</given-names></name>; <name><surname>Pang</surname><given-names>L.</given-names></name>; <name><surname>Wei</surname><given-names>F.</given-names></name>; <name><surname>Guo</surname><given-names>X.</given-names></name>; <name><surname>Jin</surname><given-names>R.</given-names></name>; <name><surname>Chen</surname><given-names>D.</given-names></name>
<article-title>Downregulated gene expression spectrum and immune responses changed
during the disease progression in patients with COVID-19</article-title>. <source>Clin. Infect. Dis.</source>
<year>2020</year>, <volume>71</volume>, <fpage>2052</fpage><pub-id pub-id-type="doi">10.1093/cid/ciaa462</pub-id>.<pub-id pub-id-type="pmid">32307550</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Shen</surname><given-names>B.</given-names></name>; <name><surname>Yi</surname><given-names>X.</given-names></name>; <name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Bi</surname><given-names>X.</given-names></name>; <name><surname>Du</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Quan</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>F.</given-names></name>; <name><surname>Sun</surname><given-names>R.</given-names></name>; <name><surname>Qian</surname><given-names>L.</given-names></name>; et al. <article-title>Proteomic and metabolomic characterization
of COVID-19 patient sera</article-title>. <source>Cell</source>
<year>2020</year>, <volume>182</volume>, <fpage>59</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.05.032</pub-id>.<pub-id pub-id-type="pmid">32492406</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Yang</surname><given-names>S.</given-names></name>; <name><surname>Fu</surname><given-names>C.</given-names></name>; <name><surname>Lian</surname><given-names>X.</given-names></name>; <name><surname>Dong</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>
<article-title>Understanding human-virus protein-protein interactions using a human
protein complex-based analysis framework</article-title>. <source>mSystems</source>
<year>2019</year>, <volume>4</volume>, <elocation-id>e00303-18</elocation-id><pub-id pub-id-type="doi">10.1128/msystems.00303-18</pub-id>.<pub-id pub-id-type="pmid">30984872</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Przyby&#x00142;a</surname><given-names>P.</given-names></name>; <name><surname>Shardlow</surname><given-names>M.</given-names></name>; <name><surname>Aubin</surname><given-names>S.</given-names></name>; <name><surname>Bossy</surname><given-names>R.</given-names></name>; <name><surname>Eckart de
Castilho</surname><given-names>R.</given-names></name>; <name><surname>Piperidis</surname><given-names>S.</given-names></name>; <name><surname>McNaught</surname><given-names>J.</given-names></name>; <name><surname>Ananiadou</surname><given-names>S.</given-names></name>
<article-title>Text mining
resources for the life sciences</article-title>. <source>Database</source>
<year>2016</year>, <volume>2016</volume>, <fpage>baw145</fpage><pub-id pub-id-type="doi">10.1093/database/baw145</pub-id>.<pub-id pub-id-type="pmid">27888231</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Rosa</surname><given-names>R. L.</given-names></name>; <name><surname>Santi</surname><given-names>L.</given-names></name>; <name><surname>Berger</surname><given-names>M.</given-names></name>; <name><surname>Tureta</surname><given-names>E. F.</given-names></name>; <name><surname>Quincozes-Santos</surname><given-names>A.</given-names></name>; <name><surname>Souza</surname><given-names>D. O.</given-names></name>; <name><surname>Guimar&#x000e3;es</surname><given-names>J. A.</given-names></name>; <name><surname>Beys-da-Silva</surname><given-names>W. O.</given-names></name>
<article-title>ZIKAVID&#x02014;Zika
virus infection database: a new
platform to analyze the molecular impact of Zika virus infection</article-title>. <source>J. NeuroVirol.</source>
<year>2019</year>, <volume>26</volume>, <fpage>77</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1007/s13365-019-00799-y</pub-id>.<pub-id pub-id-type="pmid">31512145</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Kambhampati</surname><given-names>S. B. S.</given-names></name>; <name><surname>Vaishya</surname><given-names>R.</given-names></name>; <name><surname>Vaish</surname><given-names>A.</given-names></name>
<article-title>Unprecedented
surge in publications related to COVID-19 in the first three months
of pandemic: A bibliometric analytic report</article-title>. <source>J. Clin. Orthop. Trauma</source>
<year>2020</year>, <volume>11</volume>, <fpage>S304</fpage>&#x02013;<lpage>S306</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcot.2020.04.030</pub-id>.<pub-id pub-id-type="pmid">32405191</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="weblink" id="cit14"><person-group person-group-type="allauthors"><collab>PAHO</collab></person-group>, <article-title>WHO announces a Public Health Emergency
of International Concern</article-title>; <publisher-name>Pan American
Health Organization</publisher-name>, <year>2016</year>. Available
in: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=11640:2016-who-statement-on-1st-meeting-ihr-2005-emergency-committee-on-zika-virus&#x00026;Itemid=135&#x027e8;=en">https://www.paho.org/hq/index.php?option=com_content&#x00026;view=article&#x00026;id=11640:2016-who-statement-on-1st-meeting-ihr-2005-emergency-committee-on-zika-virus&#x00026;Itemid=135&#x027e8;=en</uri>.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Neerukonda</surname><given-names>S. N.</given-names></name>; <name><surname>Katneni</surname><given-names>U.</given-names></name>
<article-title>A Review on SARS-CoV-2
virology, pathophysiology, animal models, and anti-viral interventions</article-title>. <source>Pathogens</source>
<year>2020</year>, <volume>9</volume>, <fpage>426</fpage><pub-id pub-id-type="doi">10.3390/pathogens9060426</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Esser-Nobis</surname><given-names>K.</given-names></name>; <name><surname>Aarreberg</surname><given-names>L. D.</given-names></name>; <name><surname>Roby</surname><given-names>J. A.</given-names></name>; <name><surname>Fairgrieve</surname><given-names>M. R.</given-names></name>; <name><surname>Green</surname><given-names>R.</given-names></name>; <name><surname>Gale</surname><given-names>M.</given-names><suffix>Jr.</suffix></name>
<article-title>Comparative analysis
of African and Asian lineage-derived Zika virus strains reveals differences
in activation of and sensitivity to antiviral innate immunity</article-title>. <source>J. Virol.</source>
<year>2019</year>, <volume>93</volume>, <elocation-id>e00640</elocation-id><pub-id pub-id-type="doi">10.1128/jvi.00640-19</pub-id>.<pub-id pub-id-type="pmid">31019057</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Islam</surname><given-names>M. R.</given-names></name>; <name><surname>Hoque</surname><given-names>M. N.</given-names></name>; <name><surname>Rahman</surname><given-names>M. S.</given-names></name>; <name><surname>Ul Alam</surname><given-names>A. S. M. R.</given-names></name>; <name><surname>Akther</surname><given-names>M.</given-names></name>; <name><surname>Puspo</surname><given-names>J. A.</given-names></name>; <name><surname>Akter</surname><given-names>S.</given-names></name>; <name><surname>Sultana</surname><given-names>M.</given-names></name>; <name><surname>Crandall</surname><given-names>K. A.</given-names></name>; <name><surname>Hossain</surname><given-names>M. A.</given-names></name>
<article-title>Genome-wide analysis
of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity</article-title>. <source>Sci. Rep.</source>
<year>2020</year>, <volume>10</volume>, <fpage>14004</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-70812-6</pub-id>.<pub-id pub-id-type="pmid">32814791</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Beys-da-Silva</surname><given-names>W. O.</given-names></name>; <name><surname>Rosa</surname><given-names>R. L.</given-names></name>; <name><surname>Santi</surname><given-names>L.</given-names></name>; <name><surname>Berger</surname><given-names>M.</given-names></name>; <name><surname>Park</surname><given-names>S. K.</given-names></name>; <name><surname>Campos</surname><given-names>A. R.</given-names></name>; <name><surname>Terraciano</surname><given-names>P.</given-names></name>; <name><surname>Varela</surname><given-names>A. P. M.</given-names></name>; <name><surname>Teixeira</surname><given-names>T. F.</given-names></name>; <name><surname>Roehe</surname><given-names>P. M.</given-names></name>; <name><surname>Quincozes-Santos</surname><given-names>A.</given-names></name>; <name><surname>Yates</surname><given-names>J. R.</given-names><suffix>III</suffix></name>; <name><surname>Souza</surname><given-names>D. O.</given-names></name>; <name><surname>Cirne-Lima</surname><given-names>E. O.</given-names></name>; <name><surname>Guimar&#x000e3;es</surname><given-names>J. A.</given-names></name>
<article-title>Zika virus
infection of human mesenchymal stem cells promotes differential expression
of proteins linked to several neurological diseases</article-title>. <source>Mol. Neurobiol.</source>
<year>2018</year>, <volume>56</volume>, <fpage>4708</fpage>&#x02013;<lpage>4717</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-1417-x</pub-id>.<pub-id pub-id-type="pmid">30377986</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Pickett</surname><given-names>B. E.</given-names></name>; <name><surname>Sadat</surname><given-names>E. L.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Noronha</surname><given-names>J. M.</given-names></name>; <name><surname>Squires</surname><given-names>R. B.</given-names></name>; <name><surname>Hunt</surname><given-names>V.</given-names></name>; <name><surname>Liu</surname><given-names>M.</given-names></name>; <name><surname>Kumar</surname><given-names>S.</given-names></name>; <name><surname>Zaremba</surname><given-names>S.</given-names></name>; <name><surname>Gu</surname><given-names>Z.</given-names></name>; <name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>Larson</surname><given-names>C. N.</given-names></name>; <name><surname>Dietrich</surname><given-names>J.</given-names></name>; <name><surname>Klem</surname><given-names>E. B.</given-names></name>; <name><surname>Scheuermann</surname><given-names>R. H.</given-names></name>
<article-title>ViPR: an
open bioinformatics database and analysis resource for virology research</article-title>. <source>Nucleic Acids Res.</source>
<year>2012</year>, <volume>40</volume>, <fpage>D593</fpage>&#x02013;<lpage>D598</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr859</pub-id>.<pub-id pub-id-type="pmid">22006842</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Pylro</surname><given-names>V. S.</given-names></name>; <name><surname>Oliveira</surname><given-names>F. S.</given-names></name>; <name><surname>Morais</surname><given-names>D. K.</given-names></name>; <name><surname>Cuadros-Orellana</surname><given-names>S.</given-names></name>; <name><surname>Pais</surname><given-names>F. S.-M.</given-names></name>; <name><surname>Medeiros</surname><given-names>J. D.</given-names></name>; <name><surname>Geraldo</surname><given-names>J. A.</given-names></name>; <name><surname>Gilbert</surname><given-names>J.</given-names></name>; <name><surname>Volpini</surname><given-names>A. C.</given-names></name>; <name><surname>Fernandes</surname><given-names>G. R.</given-names></name>
<article-title>ZIKV &#x02013;
CDB: a collaborative database to guide research linking sncRNAs and
Zika virus disease symptoms</article-title>. <source>PLoS Neglected
Trop. Dis.</source>
<year>2016</year>, <volume>10</volume>, <elocation-id>e0004817</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0004817</pub-id>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Guirimand</surname><given-names>T.</given-names></name>; <name><surname>Delmotte</surname><given-names>S.</given-names></name>; <name><surname>Navratil</surname><given-names>V.</given-names></name>
<article-title>VirHostNet
2.0: surfing on the web of virus/host molecular interactions data</article-title>. <source>Nucleic Acids Res.</source>
<year>2015</year>, <volume>43</volume>, <fpage>D583</fpage>&#x02013;<lpage>D587</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1121</pub-id>.<pub-id pub-id-type="pmid">25392406</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Rozenblatt-Rosen</surname><given-names>O.</given-names></name>; <name><surname>Deo</surname><given-names>R. C.</given-names></name>; <name><surname>Padi</surname><given-names>M.</given-names></name>; <name><surname>Adelmant</surname><given-names>G.</given-names></name>; <name><surname>Calderwood</surname><given-names>M. A.</given-names></name>; <name><surname>Rolland</surname><given-names>T.</given-names></name>; <name><surname>Grace</surname><given-names>M.</given-names></name>; <name><surname>Dricot</surname><given-names>A.</given-names></name>; <name><surname>Askenazi</surname><given-names>M.</given-names></name>; <name><surname>Tavares</surname><given-names>M.</given-names></name>; et al. <article-title>Interpreting
cancer genomes using systematic host perturbations by tumour virus
proteins</article-title>. <source>Nature</source>
<year>2012</year>, <volume>487</volume>, <fpage>491</fpage>&#x02013;<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1038/nature11288</pub-id>.<pub-id pub-id-type="pmid">22810586</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Ako-Adjei</surname><given-names>D.</given-names></name>; <name><surname>Fu</surname><given-names>W.</given-names></name>; <name><surname>Wallin</surname><given-names>C.</given-names></name>; <name><surname>Katz</surname><given-names>K. S.</given-names></name>; <name><surname>Song</surname><given-names>G.</given-names></name>; <name><surname>Darji</surname><given-names>D.</given-names></name>; <name><surname>Brister</surname><given-names>J. R.</given-names></name>; <name><surname>Ptak</surname><given-names>R. G.</given-names></name>; <name><surname>Pruitt</surname><given-names>K. D.</given-names></name>
<article-title>HIV-1, human interaction
database: current status and new features</article-title>. <source>Nucleic
Acids Res.</source>
<year>2014</year>, <volume>43</volume>, <fpage>D566</fpage>&#x02013;<lpage>D570</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1126</pub-id>.<pub-id pub-id-type="pmid">25378338</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="book" id="cit24"><person-group person-group-type="allauthors"><name><surname>Clough</surname><given-names>E.</given-names></name>; <name><surname>Barrett</surname><given-names>T.</given-names></name></person-group><article-title>The gene expression
omnibus database</article-title>. In <source>Statistical Genomics,
Methods in Molecular Biology</source>; <person-group person-group-type="editor"><name><surname>Math&#x000e9;</surname><given-names>E.</given-names></name>, <name><surname>Davis</surname><given-names>S.</given-names></name></person-group>, Eds.; <publisher-name>Springer</publisher-name>: <publisher-loc>New York</publisher-loc>, <year>2016</year>; Vol. <volume>1418</volume>, pp <fpage>93</fpage>&#x02013;<lpage>110</lpage>.</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Zhou</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>B.</given-names></name>; <name><surname>Pache</surname><given-names>L.</given-names></name>; <name><surname>Chang</surname><given-names>M.</given-names></name>; <name><surname>Khodabakhshi</surname><given-names>A. H.</given-names></name>; <name><surname>Tanaseichuk</surname><given-names>O.</given-names></name>; <name><surname>Benner</surname><given-names>C.</given-names></name>; <name><surname>Chandra</surname><given-names>S. K.</given-names></name>
<article-title>Metascape
provides a biologist-oriented resource for the analysis of systems-level
datasets</article-title>. <source>Nat. Commun.</source>
<year>2019</year>, <volume>10</volume>, <fpage>1523</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id>.<pub-id pub-id-type="pmid">30944313</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Kuleshov</surname><given-names>M. V.</given-names></name>; <name><surname>Stein</surname><given-names>D. J.</given-names></name>; <name><surname>Clarke</surname><given-names>D. J. B.</given-names></name>; <name><surname>Kropiwnicki</surname><given-names>E.</given-names></name>; <name><surname>Jagodnik</surname><given-names>K. M.</given-names></name>; <name><surname>Bartal</surname><given-names>A.</given-names></name>; <name><surname>Evangelista</surname><given-names>J. E.</given-names></name>; <name><surname>Hom</surname><given-names>J.</given-names></name>; <name><surname>Cheng</surname><given-names>M.</given-names></name>; <name><surname>Bailey</surname><given-names>A.</given-names></name>; <name><surname>Zhou</surname><given-names>A.</given-names></name>; <name><surname>Ferguson</surname><given-names>L. B.</given-names></name>; <name><surname>Lachmann</surname><given-names>A.</given-names></name>; <name><surname>Ma&#x02019;ayan</surname><given-names>A.</given-names></name>
<article-title>The COVID-19 Gene and Drug Set Library</article-title>. <source>Patterns</source>
<year>2020</year>, <volume>1</volume>, <fpage>100090</fpage><pub-id pub-id-type="doi">10.1016/j.patter.2020.100090</pub-id>.<pub-id pub-id-type="pmid">32838343</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Papanikolaou</surname><given-names>N.</given-names></name>; <name><surname>Pavlopoulos</surname><given-names>G. A.</given-names></name>; <name><surname>Theodosiou</surname><given-names>T.</given-names></name>; <name><surname>Iliopoulos</surname><given-names>I.</given-names></name>
<article-title>Protein&#x02013;protein interaction
predictions using
text mining methods</article-title>. <source>Methods</source>
<year>2015</year>, <volume>74</volume>, <fpage>47</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2014.10.026</pub-id>.<pub-id pub-id-type="pmid">25448298</pub-id></mixed-citation></ref></ref-list></back></article>